Thomson acquires Prous Science

"Prous Science has built a strong global brand on its flagship solutions which have been built by scientists for scientists," said Vin Caraher, President and CEO, Thomson Scientific. "This acquisition really complements our Pharma & Biotechnology workflow solution offerings. We look forward to working closely with the Prous Science management team to maximize synergies and add value for our customers."

"Today's announcement signals an excellent opportunity to accelerate our product development and innovation plan in the drug discovery space. By combining the financial strength, creativity and technology of Thomson with Prous Science, we will further drive innovations that help scientists find better solutions to their specific problems while fostering the emergence of new ideas," said Dr. J.R. Prous, President and CEO, Prous Science.